Position in GILD
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$1
-$21,854 QoQ
Shares Held
9
-97.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,266
of 2,266 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PIN OAK INVESTMENT ADVISORS INC holds $4,178,060 across 13 Drug Manufacturers - General names. GILD ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,063 | $1,793,790 | |
| 2 | ABBV |
AbbVie Inc.
|
2,819 | $709,373 | |
| 3 | PFE |
Pfizer Inc
|
24,253 | $584,012 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,079 | $395,651 | |
| 5 | LLY |
ELI LILLY & Co
|
165 | $197,905 | |
| 6 | NVS |
Novartis AG
|
1,253 | $196,370 | |
| 7 | BIIB |
Biogen Inc.
|
821 | $177,385 | |
| 8 | AMGN |
Amgen Inc
|
279 | $101,031 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1 | 9 | Shares | Sole | 2026-08-18 | |
| 2021-12-31 | $21,855 | 301 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,024 | 301 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $20,726 | 301 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $25,465 | 403 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $31,006 | 403 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $30,128 | 403 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||